Adds mucopolysaccharidosis type I and glycogen storage disorder type II to the state's newborn screening panel (EN +$187,717 GF EX See Note)
Provides relative to the mandatory screening of all newborns for early detection of the cytomegalovirus (CMV) (OR NO IMPACT See Note)
Provides relative to newborn screening for certain genetic conditions (EN SEE FISC NOTE GF EX See Note)
Requires screening of newborns for Krabbe disease (EN +$798,907 GF EX See Note)
Provides for the potential addition of mucopolysaccharidosis type I and Pompe disease to the state's newborn screening panel
Relating to requiring the Health Department to mandate mucopolysaccharidosis type 1 (MPS1) test for newborn babies, to be known as Embie’s Law
AN ACT relating to newborn and infant screenings.
AN ACT relating to newborn and infant screenings.
Requires all newborns to be screened for adrenoleukodystrophy
Requests a study concerning potential inclusion in the state's newborn screening panel of all disorders listed on the federal Recommended Uniform Screening Panel